Scandion Oncology (SCOL)

Nasdaq First North Growth Market Sweden | Biotech | Oncology/biotech
Free
No email, no account, no signup.
Pulling latest news for Scandion Oncology…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Signal
SELL
Sentiment
N/A/10
Risk
10/10
Get full analysis with Bull/Bear case, catalysts, and risk analysis
Order analysis – $4.99
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Extremely negative sentiment; discussion centered on liquidation, delisting, and likely zero recovery. Very limited chatter after delisting.
Exchange
Nasdaq First North Growth Market Sweden
Type
Biotech
Sector
Oncology/biotech
Market Cap
$2M

3 days ago 11 May 2026

Market sentiment

Extremely negative sentiment; discussion centered on liquidation, delisting, and likely zero recovery. Very limited chatter after delisting.

Why SELL ?

- **Delisted** and in liquidation → very limited investability. - High likelihood of **no** liquidation distribution to shareholders. - No operating pipeline/financing left to drive value.
  • Reduce/exit if possible; otherwise treat as a loss position and monitor the liquidator’s final notice.

Recent News

  • No new company-specific updates have been identified since 2026-04-08. The company remains delisted (last trading day 2025-07-11) and in voluntary liquidation decided on 2025-03-27; prior communication continues to indicate a shareholder distribution is unlikely.

Bull case

- **Possible** small recovery if liquidation leaves surplus (unlikely). - Costs decline as operations wind down.
Unlock to read more →

Bear case

- Shares are **delisted** and effectively illiquid.
Unlock to read more →

Dilution Risk

Assessment: Low

Order analysis – $4.99
Save hours of research. $4.99.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe

Want to read the full analysis?

Order a fresh analysis of Scandion Oncology – ready in your inbox in 5–15 minutes.

  • Signal + risk + sentiment
  • Bull/Bear case + triggers
  • Catalysts with dates
  • Saved as a webpage in your account
  • Ready in 5–15 min (email when ready)

7-day money-back guarantee · No lock-in period · Secure payment via Stripe

Fact-based analysis Updated weekly No commitment period
Scandion Oncology (SCOL)
SELL
Order analysis – $4.99
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.